Global Colorectal Cancer Diagnostics & Therapeutics Market - Segmented by diagnosis, technology and geography (2016 - 2021) - Product Image

Global Colorectal Cancer Diagnostics & Therapeutics Market - Segmented by diagnosis, technology and geography (2016 - 2021)

  • ID: 3784693
  • Report
  • Region: Global
  • 129 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Companion Dx
  • Epigenomics AG
  • Genomic Tree
  • Oncocyte (Biotime)
  • MORE
The global colorectal cancer diagnostics and therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 1-5% during the forecast period of 2015-2020. The market is valued at USD 14,143 million, as per 2015.

The CRC pipeline is highly robust, with a number of potential drug candidates present across the various phases of clinical development. With nearly 400 active pipeline molecules, the majority of the investigational drug candidates are being evaluated for the treatment of CRC in advanced stages, either as first-line or as second-line therapies. The current investigational pipeline candidates include new combination therapies and targeted therapies, as well as promising immunotherapies and chemotherapy drug candidates. Along with these active progressing pipeline molecules, the pipeline also includes nearly 180 molecules that are either inactive or discontinued.

The global colorectal cancer diagnostics and therapeutics market is segmented on the basis of:

- Diagnosis
- Digital rectal examination
- Fecal occult blood test
- Flexible sigmoidoscopy
- Colonoscopy
- Others
- Treatments
- Surgery and radiation therapy
- Targeted therapies
- Others
- Geography
- North America
- Asia-Pacific
- Europe
- Rest of the world

Some of the key players of the market are Abbott diagnostics, Alere, Beckman coulter, clinical genomics, Companion DX, EDP Biotech, Epigenomics AG, Exact sciences, Genomic tree, Metabiomics, Oncocyte, Quest Diagnostics, Randox Laboratories, Siemens Healthcare etc.

Drivers:

Increase of pipeline colorectal cancer screening tests
Aging population
Increasing consumer awareness
Restraints:

Cost of screening test
Counselling

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Companion Dx
  • Epigenomics AG
  • Genomic Tree
  • Oncocyte (Biotime)
  • MORE
1. Introduction
1.1 Report Description
1.2 Research Methodology
2 Executive summary
3. Market overview
3.1 Market definition
3.2 Market drivers
3.2.1 Increase of Pipeline Colorectal Cancer Screening Tests
3.2.2 Aging Population
3.2.3 Increasing Consumer Awareness
3.3 Market restraints
3.3.1 screening test costs
3.3.2 Counseling
3.4 Market opportunities
4. Portors five force analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of comprtition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market segmentation
5.1 By diagnosis
5.1.2 Digital Rectal Examination
5.1.3 Fecal Occult Blood Test
5.1.4 Flexible Sigmoidoscopy
5.1.5 Colonoscopy
5.1.6 Virtual Colonoscopy
5.2 By treatment
5.2.1 Surgery and Radiation Therapy
5.2.2 Chemotherapy
5.2.3 Targeted Therapies
5.2.4 Resistance to Pharmacological Therapies
5.3 By geography
5.3.3 Middle East & Africa
5.3.3.1 Qatar
5.3.3.2 Saudi Arabia
5.3.3.3 South Africa
6.Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Partnerships and Collaborations
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company profiles
7.1 Abbott Diagnostics
7.2 Alere
7.3 Beckman Coulter
7.4 Clinical Genomics
7.5 Companion Dx
7.6 EDP Biotech
7.7 Epigenomics AG
7.8 Exact Sciences
7.9 Fujirebio (Miraca Holdings)
7.10 Genomic Tree
7.11 Metabiomics
7.12 Oncocyte (Biotime)
7.13 Quest Diagnostics
7.14 Randox Laboratories
7.15 Siemens Healthcare
7.16 Volition Rx
8Appendix
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Clinical Genomics
  • Companion Dx
  • EDP Biotech
  • Epigenomics AG
  • Exact Sciences
  • Fujirebio (Miraca Holdings)
  • Genomic Tree
  • Metabiomics Corporation
  • Oncocyte (Biotime)
  • Quest Diagnostics
  • Randox Laboratories
  • Siemens Healthcare
  • Volition Rx
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll